Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jul 2021

Bergeron Anthony, MacGrogan Gaëtan, Bertaut Aurélie, Ladoire Sylvain, Arveux Patrick, Desmoulins Isabelle, Bonnefoi Hervé, Loustalot Catherine, Auriol Sophie, Beltjens Françoise, Degrolard-Courcet Emilie, Charon-Barra Céline, Richard Corentin, Boidot Romain, Arnould Laurent

Abstract excerpt

Primary triple-negative invasive lobular breast carcinomas (TN-ILCs), which do not express hormone receptors and HER2 at diagnosis, are rare and poorly known. In this study, we analyzed the largest TN-ILC series ever reported in the literature, in comparison to phenotypically similar breast tumor subtypes: triple-negative invasive ductal carcinoma (TN-IDC) and hormone receptor-positive invasive lobular carcinoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carcinoma, Lobular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Phosphatidylinositol 3-Kinases

Share to Receptor, ErbB-2

Share to Receptors, Androgen

Share to Receptors, Estrogen

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33753865
DOI: 10.1038/s41379-021-00742-9
PMCID: PMC8216909

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.PMID 33753865Read ↗

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsSemantic proximity Read ↗

Genomic Characterization of Primary Invasive Lobular Breast Cancer.Semantic proximity Read ↗

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.Semantic proximity Read ↗

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.Semantic proximity Read ↗

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.Semantic proximity Read ↗

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.Semantic proximity Read ↗

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerSemantic proximity Read ↗

Clinicopathological and genetic analysis of 55 male patients with invasive breast cancerSemantic proximity Read ↗

Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity Read ↗

Invasive Lobular Carcinoma Cell Lines Are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen ResponseSemantic proximity Read ↗

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerSemantic proximity Read ↗

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.